510(k) Report

510(k) · Cleared

Cleared

Certa Dose Pediatric Midazolam 5mg/mL IM Syringe

K180683510(k) TraditionalCleared Nov 7, 2018237-day reviewClass II21 CFR 880.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Certa Dose, Inc. · PQX Epinephrine Syringe

Cleared on Nov 7, 2018 as substantially equivalent to K851090 (Sherwood Medical Co., 1985) after a 237-day review. Its family tree reaches back 1 generation to 1985.

Decided
Nov 7, 2018
Review
237 days
Class
Class II
Product code
PQX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K851090 (1985). No later device cites it as a predicate yet.

  1. Root · 1 generation backK851090 Monoject Sterile 1/2 CC & 1CC Syringes W & W/O NeeSherwood Medical Co. · 1985 · Recalled
  2. This deviceK180683 Certa Dose Pediatric Midazolam 5mg/mL IM SyringeCerta Dose, Inc. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K851090Monoject Sterile 1/2 CC & 1CC Syringes W & W/O NeeSherwood Medical Co.19851
0 (this device)K180683Certa Dose Pediatric Midazolam 5mg/mL IM SyringeCerta Dose, Inc.2018—
FIG. 1 — Lineage of K180683, 1985–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PQX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K851090Monoject Sterile 1/2 CC & 1CC Syringes W & W/O Nee
Summary page 4
…ulation: Piston Syringe, 21 CFR 880.5860 Regulatory Class: II Product Code: QDM, Midazolam Syringe III. PREDICATE DEVICES Predicate: Monoject 1mL Tuberculin Syringe, K851090 Reference Device: Certa Dose™ PD Epinephrine 1 mg/mL IM/SC Syringe, K160589 IV. DEVICE DESCRIPTION The Certa Dose™ Pediatric…
Sherwood Medical Co.19851
†K160589Certa Dose PD Epinephrine 1mg/mL IM/SC SyringeCerta Dose, Inc.2017—

Also cleared against K851090: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 2 other devices also cite its predicate K851090.

How does its category compare?

All PQX devices

PQX Epinephrine Syringe: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · PQX

1in 2018

2017: 12018: 1
2007high 1 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PQX

Too few PQX 510(k)s in any year since 2007 to give a median.

Recalls per year · PQX

No recall names PQX since 2007.

Adverse event reports per year · PQX

27in 2025

2022: 12024: 202025: 27
2007high 27 (2025) · low 0 (2007)2025

MAUDE reports naming product code PQX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20181—00
20190—00
20200—00
20210—00
20220—01
20230—00
20240—020
20250—027
20260—0—

What is it indicated for?

The Certa Dose™ Pediatric Midazolam 5 mg/mL intramuscular (IM) Syringe is intended for the delivery of midazolam 5 mg/mL for use in pediatric (non-neonatal) patients up to 30kg in weight.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K180683: Certa Dose Pediatric Midazolam 5mg/mL IM Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180683

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026